Tag: CDSCO

After adequate examination, Central Drugs Standard Control Organisation decided to accept the recommendations of the Expert Committee, and accordingly, vaccines of Serum and Bharat Biotech are being approved for restricted use in an emergency situation

New Delhi: Zydus Cadila has announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was found to be safe, well tolerated and immunogenic in...

As per Dr V G Somani, Drugs Controller General of India, the medical device industry needs to look at quality, affordability, and access, and service delivery while developing products from a pricing and regulatory perspective..........................

Medical Technology Association of India has welcomed two latest notices from the Central Drugs Standard Control Organization (CDSCO) that address operational and regulatory challenges faced by the medical device industry...........

The Drugs Controller General of India has given the Serum Institute of India a green light to conduct phase 2 and 3 human trials of the Oxford-AstraZeneca COVID-19 vaccine candidate in India..................

Oxiris Blood Purification Filter is intended for use in critically ill COVID-19 patients in need of Blood Purification where excessive Inflammatory Mediators are present i.e. Cytokine Storm release.........................

Human trials of India’s first indigenous experimental vaccine against COVID-19, COVAXIN, developed by Bharat Biotech is set to begin across India in July........................

Approval from the New Drugs Division of Central Drugs Standard Control Organization (CDSCO) will pave way for CSIR-Indian Institute of Integrative Medicine (IIIM) Jammu for conducting the clinical trial of this important drug candidate IIIM-290 in pancreatic cancer patients....................

The conference will be focused on ‘Beyond New Regulations- Increasing Participation and Enhancing Patient Safety’. While Dr V G Somani, Drug Controller General India, CDSCO, to be the Chief Guest, Dr Gagandeep Kang, Executive Director, THSTI will deliver late Prof Ranjit Roy Chaudhury Oration........................

CDSCO approval was granted following the completion of the CoSara manufacturing facility and a comprehensive inspection of the location, presentation of the technology, quality system, procedures, product validation data and performance evaluation by an independent NABL & CAP accredited laboratory..........